Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation

This publication has 15 references indexed in Scilit:

• Cholesterol-Lowering Treatment Is Associated With Improvement in Coronary Vascular Remodeling and Endothelial Function in Patients With Normal or Mildly Diseased Coronary Arteries
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Coronary Artery Disease in the Transplanted Heart
  Annual Review of Medicine, 2000
• Vascular Endothelium, Hemodynamic Forces, and Atherogenesis
  The American Journal of Pathology, 1999
• Development of Transplantation Vasculopathy and Progression of Donor-Transmitted Atherosclerosis
  Circulation, 1998
• Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation
  Circulation, 1997
• Effect of Pravastatin on Outcomes after Cardiac Transplantation
  New England Journal of Medicine, 1995
• The Effect of Cholesterol-Lowering and Antioxidant Therapy on Endothelium-Dependent Coronary Vasomotion
  New England Journal of Medicine, 1995
• Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors
  The American Journal of Cardiology, 1994
• Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia.
  Circulation, 1994
• Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendations
  Journal of the American College of Cardiology, 1992